Cynata Therapeutics Limited

CYYNF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$10-$14-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$0-$1
Stock-Based Comp.$0$0$0$1
Change in WC$0-$1-$1$1
Other Non-Cash-$9$1$0$1
Operating Cash Flow-$9-$10-$14-$3
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$8$0$7$0
Stock Repurch.-$1$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$8$0$7$0
Forex Effect-$0-$0-$0$0
Net Chg. in Cash-$1-$10-$8-$3
Supplemental Information
Beg. Cash$6$16$24$27
End Cash$5$6$16$24
Free Cash Flow-$9-$10-$14-$3
Cynata Therapeutics Limited (CYYNF) Financial Statements & Key Stats | AlphaPilot